US20020099067A1
(en)
*
|
1993-07-08 |
2002-07-25 |
Ulrich Posanski |
Pharmaceutical compositions for sparingly soluble therapeutic agents
|
GB9325445D0
(en)
|
1993-12-13 |
1994-02-16 |
Cortecs Ltd |
Pharmaceutical formulations
|
CH686865A5
(de)
*
|
1994-06-15 |
1996-07-31 |
Gergely Gerhard |
Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
|
US5545628A
(en)
*
|
1995-01-10 |
1996-08-13 |
Galephar P.R. Inc. |
Pharmaceutical composition containing fenofibrate
|
GB9525194D0
(en)
*
|
1995-12-12 |
1996-02-07 |
Zeneca Ltd |
Pharmaceutical composition
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
US5955098A
(en)
*
|
1996-04-12 |
1999-09-21 |
Flemington Pharmaceutical Corp. |
Buccal non polar spray or capsule
|
GB9608719D0
(en)
*
|
1996-04-26 |
1996-07-03 |
Scherer Ltd R P |
Pharmaceutical compositions
|
CA2258879A1
(en)
*
|
1996-06-28 |
1998-01-08 |
Novartis Ag |
Pesticidal compositions
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US5788978A
(en)
*
|
1996-12-17 |
1998-08-04 |
Passeron; Eduardo Julio |
Injectable pulsatile ivermectin composition
|
FR2758459B1
(fr)
*
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
CN1252711A
(zh)
*
|
1997-04-18 |
2000-05-10 |
大正制药株式会社 |
微乳
|
CA2285983A1
(en)
*
|
1997-04-29 |
1998-11-05 |
Bernard Charles Sherman |
Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
|
US20030133974A1
(en)
*
|
1997-07-01 |
2003-07-17 |
Curatolo William John |
Encapsulated solution dosage forms of sertraline
|
IS4518A
(is)
*
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
DE69804624T2
(de)
*
|
1997-07-29 |
2002-09-19 |
Upjohn Co |
Selbstemulgierende formulierung enthaltend lipophile verbindungen
|
US6346511B1
(en)
|
1997-09-08 |
2002-02-12 |
Panacea Biotec Limited |
Pharmaceutical composition comprising cyclosporin
|
US6187747B1
(en)
|
1997-09-08 |
2001-02-13 |
Panacea Biotech Limited |
Pharmaceutical composition comprising cyclosporin
|
US6008191A
(en)
*
|
1997-09-08 |
1999-12-28 |
Panacea Biotec Limited |
Pharmaceutical compositions containing cyclosporin
|
US6281175B1
(en)
|
1997-09-23 |
2001-08-28 |
Scimed Life Systems, Inc. |
Medical emulsion for lubrication and delivery of drugs
|
US6054421A
(en)
*
|
1997-09-23 |
2000-04-25 |
Scimed Life Systems, Inc. |
Medical emulsion lubricant
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
US20050180923A1
(en)
*
|
1997-10-01 |
2005-08-18 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing testosterone
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
US20050163719A1
(en)
*
|
1997-10-01 |
2005-07-28 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing diazepam
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
US20030077229A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
US7632517B2
(en)
*
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
US20030082107A1
(en)
*
|
1997-10-01 |
2003-05-01 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
|
US20050281752A1
(en)
*
|
1997-10-01 |
2005-12-22 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
US20090162300A1
(en)
*
|
1997-10-01 |
2009-06-25 |
Dugger Iii Harry A |
Buccal, polar and non-polar spray containing alprazolam
|
US20030185761A1
(en)
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
US20040136914A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
US20050287075A1
(en)
*
|
1997-10-01 |
2005-12-29 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
EP1029536B1
(de)
*
|
1997-10-01 |
2007-11-28 |
Novadel Pharma Inc. |
Nichtpolare Spray zur bukkalen Verabreichung
|
US6063762A
(en)
*
|
1997-12-05 |
2000-05-16 |
Chong Kun Dang Corp. |
Cyclosporin-containing microemulsion preconcentrate composition
|
AU735084B2
(en)
*
|
1998-02-09 |
2001-06-28 |
Joel Bolonick |
Treatment of chronic inflammatory disorders of the gastrointestinal tract
|
DE69914742T2
(de)
|
1998-05-29 |
2004-11-25 |
Skyepharma Canada Inc., Verdun |
Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
|
FR2782006B1
(fr)
*
|
1998-08-07 |
2002-04-19 |
Gattefosse Ets Sa |
Composition a liberation prolongee apte a former une micro-emulsion
|
US6551613B1
(en)
*
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
JP3557579B2
(ja)
*
|
1998-09-11 |
2004-08-25 |
株式会社三協 |
ソフトカプセル剤
|
ID29270A
(id)
|
1998-11-20 |
2001-08-16 |
Rtp Pharma Inc |
Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar
|
CN1236813C
(zh)
|
1998-12-11 |
2006-01-18 |
药品处理公司 |
水难溶性药物的自乳化组合物
|
US6814977B1
(en)
|
1998-12-18 |
2004-11-09 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
WO2000037057A2
(en)
*
|
1998-12-18 |
2000-06-29 |
Abbott Laboratories |
Novel formulations comprising lipid-regulating agents
|
US7014864B1
(en)
*
|
1998-12-18 |
2006-03-21 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US6838091B2
(en)
*
|
1998-12-18 |
2005-01-04 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
JP2002534370A
(ja)
|
1998-12-30 |
2002-10-15 |
デクセル リミテッド |
サイクロスポリンを送達するための分散可能な濃縮物
|
US6383517B1
(en)
|
1999-01-29 |
2002-05-07 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
US6368622B2
(en)
|
1999-01-29 |
2002-04-09 |
Abbott Laboratories |
Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
|
US20030026835A1
(en)
*
|
1999-02-15 |
2003-02-06 |
Sumitomo Pharmaceuticals Company Limited |
Tablets disintegrating rapidly in the oral cavity
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
JP2003531099A
(ja)
*
|
1999-03-24 |
2003-10-21 |
エフ エム シー コーポレーション |
改良された水溶解度をもつ医薬製剤
|
US6616942B1
(en)
*
|
1999-03-29 |
2003-09-09 |
Soft Gel Technologies, Inc. |
Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
|
US6719999B2
(en)
|
1999-03-31 |
2004-04-13 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
EP1162954A1
(de)
*
|
1999-03-31 |
2001-12-19 |
Abbott Laboratories |
Neue formulierungen mit lipid regulierenden wirkstoffen
|
EP1165141A2
(de)
*
|
1999-03-31 |
2002-01-02 |
Abbott Laboratories |
Neue formulierungen mit lipid regulierenden wirkstoffen
|
US6652880B1
(en)
|
1999-04-01 |
2003-11-25 |
R.P. Scherer Technologies, Inc. |
Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
|
GB9907715D0
(en)
*
|
1999-04-01 |
1999-05-26 |
Scherer Corp R P |
Pharmaceutical compositions
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
US6057289A
(en)
*
|
1999-04-30 |
2000-05-02 |
Pharmasolutions, Inc. |
Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
|
US6465011B2
(en)
|
1999-05-29 |
2002-10-15 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US6372251B2
(en)
|
1999-06-11 |
2002-04-16 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US20030235595A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
|
US6982281B1
(en)
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
CN1174741C
(zh)
*
|
1999-09-21 |
2004-11-10 |
Rtp药品公司 |
生物活性物质的表面改性微粒组合物
|
EP1225879A2
(de)
*
|
1999-10-22 |
2002-07-31 |
Orbon Corporation |
Ophthalmische zusammensetzung enthaltend dopaminantagonisten
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20060034937A1
(en)
*
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6632429B1
(en)
|
1999-12-17 |
2003-10-14 |
Joan M. Fallon |
Methods for treating pervasive development disorders
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
FR2803203B1
(fr)
*
|
1999-12-31 |
2002-05-10 |
Fournier Ind & Sante |
Nouvelles formulations galeniques du fenofibrate
|
US20020102301A1
(en)
*
|
2000-01-13 |
2002-08-01 |
Joseph Schwarz |
Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
|
US20050037073A1
(en)
*
|
2000-01-13 |
2005-02-17 |
Alpharx Inc. |
Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
|
GB0001449D0
(en)
*
|
2000-01-21 |
2000-03-08 |
Cortendo Ab |
Compositions
|
EP1273287A1
(de)
*
|
2000-04-04 |
2003-01-08 |
Shionogi & Co., Ltd. |
Ölige zubereitungen enthaltend stark fettlösliche wirkstoffe
|
US6365181B1
(en)
|
2000-04-20 |
2002-04-02 |
Gattefosse Corporation |
Thixatropic gelatin carrier composition
|
AU6608701A
(en)
*
|
2000-06-21 |
2002-01-02 |
Audit Institute For Medical Services And Quality Assurance Gmbh |
Pharmaceutical preparations containing cyclosporines and neutral oils
|
US6623734B2
(en)
*
|
2000-06-22 |
2003-09-23 |
Soft Gel Technologies, Inc. |
Super absorption coenzyme Q10
|
AUPQ875700A0
(en)
*
|
2000-07-13 |
2000-08-03 |
Reflex Research Limited |
Combination compositions
|
US6491950B1
(en)
*
|
2000-08-07 |
2002-12-10 |
Kos Pharmaceuticals, Inc. |
Controlled release pharmaceutical composition
|
EP1307097A4
(de)
*
|
2000-08-10 |
2004-01-28 |
Delsys Pharmaceutical Corp |
Verbesserte feste darreichungsform von hydrophoben wirkstoffen
|
US20070053895A1
(en)
*
|
2000-08-14 |
2007-03-08 |
Fallon Joan M |
Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US8030002B2
(en)
|
2000-11-16 |
2011-10-04 |
Curemark Llc |
Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
|
GB0101198D0
(en)
|
2001-01-17 |
2001-02-28 |
Scherer Technologies Inc R P |
Ingestible compositions containing an odoriferous oil
|
WO2002069936A2
(en)
*
|
2001-03-02 |
2002-09-12 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical composition of ibuprofen
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
WO2002072150A2
(en)
*
|
2001-03-13 |
2002-09-19 |
Angiotech Pharmaceuticals Inc. |
Micellar drug delivery vehicles and uses thereof
|
BR0208626A
(pt)
*
|
2001-04-03 |
2004-03-09 |
Schering Corp |
Composição antifúngica com biodisponibilidade intensificada
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
DE60220519T2
(de)
*
|
2001-04-20 |
2007-09-27 |
The University Of British Columbia, Vancouver |
Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe
|
AUPR510001A0
(en)
*
|
2001-05-18 |
2001-06-14 |
Jupitar Pty Ltd |
Formulation and method
|
ATE358477T1
(de)
*
|
2001-06-12 |
2007-04-15 |
Galephar M F |
Oral anzuwendende arzneizusammensetzung enthaltend ein statinderivat
|
EP1269994A3
(de)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
|
WO2003002095A1
(fr)
*
|
2001-06-28 |
2003-01-09 |
Chugai Seiyaku Kabushiki Kaisha |
Preparation d'une micro-emulsion de type huile-eau
|
BR0210722A
(pt)
*
|
2001-06-29 |
2004-07-20 |
Medgraft Microtech Inc |
Implantes injetáveis biodegradáveis e métodos relacionados de produção e uso
|
US7173064B2
(en)
*
|
2001-07-09 |
2007-02-06 |
Repros Therapeutics Inc. |
Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy
|
US7737185B2
(en)
*
|
2001-07-09 |
2010-06-15 |
Repros Therapeutics Inc. |
Methods and compositions with trans-clomiphene
|
PL211339B1
(pl)
*
|
2001-07-09 |
2012-05-31 |
Zonagen |
Zastosowanie kompozycji do wytwarzania leku do leczenia niedoboru testosteronu u samców ssaków
|
US6720002B2
(en)
*
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
US20050009762A1
(en)
*
|
2003-06-06 |
2005-01-13 |
Strobel Michael Albert |
Application of water and organic solvent soluble ivermectin for topical and oral use
|
GB0119480D0
(en)
*
|
2001-08-09 |
2001-10-03 |
Jagotec Ag |
Novel compositions
|
US6488952B1
(en)
|
2001-08-28 |
2002-12-03 |
John P. Kennedy |
Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
|
FR2829028B1
(fr)
*
|
2001-08-29 |
2004-12-17 |
Aventis Pharma Sa |
Association d'un antagoniste du recepteur cb1 et d'un produit qui active la neurotransmission dopaminergique dans le cerveau, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de
|
US6479060B1
(en)
|
2001-09-04 |
2002-11-12 |
Healthpoint, Ltd. |
Elegant hydrogenated castor oil ointments
|
RU2302233C2
(ru)
*
|
2001-09-10 |
2007-07-10 |
Ф.Хоффманн-Ля Рош Аг |
Масляные тиксотропные композиции
|
GB0125061D0
(en)
*
|
2001-10-18 |
2001-12-12 |
Norton Healthcare Ltd |
Pharmaceutical composition
|
US6462083B1
(en)
|
2001-11-13 |
2002-10-08 |
Sarfaraz K. Niazi |
Suppository base
|
WO2003041632A2
(en)
|
2001-11-14 |
2003-05-22 |
Texas Tech University |
Eutectic-based self-nanoemulsified drug delivery system
|
EA008072B1
(ru)
*
|
2001-12-03 |
2007-02-27 |
Новацея, Инк. |
Фармацевтические составы, содержащие соединения активного витамина d
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
US8100844B2
(en)
*
|
2002-04-25 |
2012-01-24 |
Ultraflex Systems, Inc. |
Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint
|
US20050287203A1
(en)
*
|
2002-05-08 |
2005-12-29 |
Nijs De H |
Formulation comprising testosteron undecanoate and castor oil
|
US6890558B2
(en)
*
|
2002-05-31 |
2005-05-10 |
R.P. Scherer Technologies, Inc. |
Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
|
US20030232097A1
(en)
*
|
2002-06-17 |
2003-12-18 |
Strides Inc. |
Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
|
US6855332B2
(en)
*
|
2002-07-03 |
2005-02-15 |
Lyfjathroun Hf. |
Absorption promoting agent
|
KR100533458B1
(ko)
*
|
2002-07-20 |
2005-12-07 |
대화제약 주식회사 |
파클리탁셀의 가용화용 조성물 및 그의 제조 방법
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
GB2391471B
(en)
*
|
2002-08-02 |
2005-05-04 |
Satishchandra Punambhai Patel |
Pharmaceutical compositions
|
US20040053895A1
(en)
*
|
2002-09-18 |
2004-03-18 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US20040058895A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
EP1569515A4
(de)
*
|
2002-10-23 |
2006-04-26 |
Glaxosmithkline Biolog Sa |
Malaria-impfverfahren
|
US7544674B2
(en)
*
|
2002-10-25 |
2009-06-09 |
Galderma S.A. |
Topical skin care composition
|
US7374772B2
(en)
*
|
2002-11-07 |
2008-05-20 |
Bommarito Alexander A |
Topical antifungal treatment
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
TW200409644A
(en)
*
|
2002-12-04 |
2004-06-16 |
Bio Max Inc |
Improved carrier system for cyclosporin pharmaceutical compositions
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
WO2004062692A1
(en)
*
|
2003-01-13 |
2004-07-29 |
Solvay Pharmaceuticals B.V. |
Formulation of poorly water-soluble active substances
|
US7323206B1
(en)
|
2003-03-04 |
2008-01-29 |
B. Braun Medical Inc. |
Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
|
JP2006521366A
(ja)
*
|
2003-03-28 |
2006-09-21 |
シグモイド・バイオテクノロジーズ・リミテッド |
シームレスマイクロカプセルを含む固形経口剤形
|
US20040191207A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Lipari John M. |
Alpha-hydroxy acid ester drug delivery compositions and methods of use
|
GB0308732D0
(en)
*
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Absorption enhancers
|
GB0308734D0
(en)
*
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Uptake of macromolecules
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
EP1498123A1
(de)
*
|
2003-07-18 |
2005-01-19 |
Aventis Pharma S.A. |
Emulgierende Systeme enthaltend Azetidin Derivate
|
US7419996B2
(en)
*
|
2003-08-13 |
2008-09-02 |
The University Of Houston |
Parenteral and oral formulations of benzimidazoles
|
US20080089877A1
(en)
*
|
2003-08-14 |
2008-04-17 |
Udell Ronald G |
Super Absorption Coenzyme Q10
|
US7169385B2
(en)
*
|
2003-09-29 |
2007-01-30 |
Ronald G. Udell |
Solubilized CoQ-10 and carnitine
|
US8124072B2
(en)
|
2003-09-29 |
2012-02-28 |
Soft Gel Technologies, Inc. |
Solubilized CoQ-10
|
US8105583B2
(en)
|
2003-09-29 |
2012-01-31 |
Soft Gel Technologies, Inc. |
Solubilized CoQ-10
|
WO2005037251A1
(en)
*
|
2003-10-17 |
2005-04-28 |
Amylin Pharmaceuticals, Inc. |
Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
|
FR2861261B1
(fr)
*
|
2003-10-22 |
2007-11-16 |
Adisseo France Sas |
Procede zootechnique pour l'administation d'un derive de vitamine e et formulation
|
FR2861992B1
(fr)
*
|
2003-11-10 |
2007-07-20 |
Sanofi Synthelabo |
Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
|
US8784869B2
(en)
|
2003-11-11 |
2014-07-22 |
Mattern Pharma Ag |
Controlled release delivery system for nasal applications and methods of treatment
|
ATE319426T1
(de)
*
|
2003-11-11 |
2006-03-15 |
Mattern Udo |
Nasenformulierung mit kontrollierter freisetzung von sexualhormonen
|
US8062664B2
(en)
*
|
2003-11-12 |
2011-11-22 |
Abbott Laboratories |
Process for preparing formulations of lipid-regulating drugs
|
CN1257711C
(zh)
*
|
2003-12-05 |
2006-05-31 |
石药集团中奇制药技术(石家庄)有限公司 |
丁苯酞软胶囊及其制备工艺
|
CA2560298A1
(en)
*
|
2004-03-24 |
2005-09-29 |
Takeda Pharmaceutical Company Limited |
Preparation with elevated content
|
US20060177512A1
(en)
*
|
2004-04-05 |
2006-08-10 |
Yihong Qiu |
Process for preparing formulations of lipid-regulating drugs
|
WO2006097793A2
(en)
*
|
2004-04-15 |
2006-09-21 |
Chiasma, Ltd. |
Compositions capable of facilitating penetration across a biological barrier
|
US20070219131A1
(en)
*
|
2004-04-15 |
2007-09-20 |
Ben-Sasson Shmuel A |
Compositions capable of facilitating penetration across a biological barrier
|
PL1742618T3
(pl)
*
|
2004-05-04 |
2013-01-31 |
Hormos Medical Ltd |
Nowe doustne preparaty ospemifenu
|
US8758821B2
(en)
|
2004-05-04 |
2014-06-24 |
Hormos Medical Ltd. |
Oral formulations of ospemifene
|
US8075910B2
(en)
*
|
2004-05-20 |
2011-12-13 |
Pbm Pharmaceuticals, Inc. |
Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
|
WO2005120517A1
(en)
*
|
2004-06-07 |
2005-12-22 |
Strides Arcolab Limited |
Stable liquid suspension formulation comprising synthetic steroids and process for producing the same
|
BRPI0513129A
(pt)
*
|
2004-07-14 |
2008-04-29 |
Repros Therapeutics Inc |
método de tratamento de condição selecionada do grupo que consiste em hipertrofia benigna de próstata, cáncer de próstata, trigliceridos elevados, colesterol alto e hipogonadismo
|
BRPI0515122A
(pt)
*
|
2004-08-31 |
2008-07-08 |
Akzo Nobel Nv |
método para solubilização de pigmento, uma composição de pigmento e seu uso
|
WO2006033435A1
(ja)
*
|
2004-09-24 |
2006-03-30 |
Hi-Lex Corporation |
生体硬組織または軟組織誘導性スカフォールド材料
|
US20080020018A1
(en)
*
|
2004-09-27 |
2008-01-24 |
Joey Moodley |
Combination Products
|
US8026281B2
(en)
*
|
2004-10-14 |
2011-09-27 |
Lupin Atlantis Holdings, S.A. |
Treating metabolic syndrome with fenofibrate
|
AU2005309808A1
(en)
*
|
2004-11-24 |
2006-06-01 |
Merck & Co., Inc. |
Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
|
US20060211762A1
(en)
*
|
2004-12-06 |
2006-09-21 |
Rongen Roelof M |
Omega-3 fatty acids and dyslipidemic agent for lipid therapy
|
WO2006062933A2
(en)
*
|
2004-12-06 |
2006-06-15 |
Reliant Pharmaceuticals, Inc. |
Stable compositions of fenofibrate with fatty acid esters
|
US20060140820A1
(en)
|
2004-12-28 |
2006-06-29 |
Udo Mattern |
Use of a container of an inorganic additive containing plastic material
|
PL219509B1
(pl)
*
|
2005-02-04 |
2015-05-29 |
Repros Therapeutics Inc |
Zastosowanie kompozycji zawierającej trans-klomifen
|
CN101208083A
(zh)
*
|
2005-03-08 |
2008-06-25 |
瑞莱恩特医药品有限公司 |
利用他汀和Omega-3脂肪酸治疗及其组合产品
|
CN101141953A
(zh)
|
2005-03-21 |
2008-03-12 |
伊瓦克斯制药有限公司 |
结晶抑制剂及其在明胶胶囊中的用途
|
RU2413508C2
(ru)
|
2005-03-22 |
2011-03-10 |
Репрос Терапьютикс Инк. |
Режимы дозирования транс-кломифена
|
US7276113B2
(en)
*
|
2005-04-07 |
2007-10-02 |
U.S. Cosmetics Corporation |
Self-emulsifying pigments
|
US8492369B2
(en)
|
2010-04-12 |
2013-07-23 |
Clarus Therapeutics Inc |
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
|
WO2006113505A2
(en)
|
2005-04-15 |
2006-10-26 |
Clarus Therapeutics, Inc. |
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
|
WO2006119660A1
(en)
*
|
2005-05-11 |
2006-11-16 |
Givaudan Sa |
Encapsulation method
|
EP1893182B8
(de)
*
|
2005-05-26 |
2012-04-04 |
Teva Women's Health, Inc. |
Orale dosierformen mit progesteron und verwendungs- und herstellungsverfahren dafür
|
JP4889262B2
(ja)
*
|
2005-08-19 |
2012-03-07 |
理研ビタミン株式会社 |
脂溶性薬剤組成物
|
US20080058282A1
(en)
|
2005-08-30 |
2008-03-06 |
Fallon Joan M |
Use of lactulose in the treatment of autism
|
CH698325B1
(fr)
*
|
2005-09-22 |
2009-07-15 |
Ramachandran Radhakrishnan |
Nouvel agent permettant d'augmenter la solubilité et le procédé utilisant celui-ci.
|
EP1959926A1
(de)
*
|
2005-10-25 |
2008-08-27 |
Abbott Laboratories |
Formulierung mit einem arzneimittel geringer wasserlöslichkeit und anwendungsverfahren
|
EP1942872A2
(de)
*
|
2005-11-04 |
2008-07-16 |
Eastman Chemical Company |
Carboxyalkylcelluloseester zur verabreichung von schwer löslichen pharmazeutischen wirkstoffen
|
ATE516016T1
(de)
|
2005-12-05 |
2011-07-15 |
Merck Sharp & Dohme |
Selbstemulgierende formulierungen von cetp- hemmern
|
EP2015632B1
(de)
*
|
2006-04-19 |
2015-12-02 |
Mist Pharmaceuticals, LLC |
Stabile wässrig-alkoholische mundsprayformulierungen und verfahren
|
EP2023957A2
(de)
*
|
2006-06-07 |
2009-02-18 |
Morton Grove Pharmaceuticals, Inc. |
Orale flüssige loratadinformulierungen und verfahren
|
CN101495150B
(zh)
*
|
2006-08-01 |
2011-06-01 |
大塚制药株式会社 |
药理活性物质的吸收性被改善的药物组合物
|
CA2558202A1
(en)
*
|
2006-09-14 |
2006-11-23 |
Reinhold W. Vieth |
Vitamin d compositions and method of administration to infants
|
AU2007304471B2
(en)
|
2006-10-04 |
2012-09-06 |
M & P Patent Aktiengesellschaft |
Controlled release delivery system for nasal application of neurotransmitters
|
KR101441459B1
(ko)
*
|
2006-10-24 |
2014-09-18 |
헬신 헬쓰케어 에스.에이. |
안정성 및 생체이용률이 개선된 염산 팔로노세트론을 포함하는 연질 캡슐
|
CA2673049C
(en)
*
|
2006-12-22 |
2016-02-23 |
Novadel Pharma Inc. |
Stable anti-nausea oral spray formulations and methods
|
EP1961412A1
(de)
|
2006-12-27 |
2008-08-27 |
LEK Pharmaceuticals D.D. |
Selbstmikroemulgierende Arzneimittelabgabesysteme
|
US10265265B2
(en)
|
2007-03-15 |
2019-04-23 |
Drug Delivery Solutions Limited |
Topical composition
|
US8343541B2
(en)
|
2007-03-15 |
2013-01-01 |
Soft Gel Technologies, Inc. |
Ubiquinol and alpha lipoic acid compositions
|
DE102007015701A1
(de)
*
|
2007-03-19 |
2008-09-25 |
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh |
Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung
|
CA2683415C
(en)
|
2007-04-04 |
2020-12-08 |
Sigmoid Pharma Limited |
An oral pharmaceutical composition
|
EP2586428B1
(de)
|
2007-04-26 |
2023-11-08 |
Sublimity Therapeutics Limited |
Herstellung mehrerer Minikapseln
|
EP2063875A2
(de)
*
|
2007-05-01 |
2009-06-03 |
Sigmoid Pharma Limited |
Pharmazeutische kombinationszusammensetzungen
|
CN101801346A
(zh)
*
|
2007-05-10 |
2010-08-11 |
诺瓦德尔药品公司 |
抗失眠症组合物及方法
|
EP2008651A1
(de)
|
2007-06-26 |
2008-12-31 |
Drug Delivery Solutions Limited |
Biologisch erodierbares Patch
|
EP2200613B1
(de)
|
2007-09-21 |
2018-09-05 |
The Johns Hopkins University |
Phenazin-derivate und ihre verwendungen
|
EP2044930A1
(de)
*
|
2007-10-01 |
2009-04-08 |
Nestec S.A. |
Zusammensetzung zur Steuerung Lipase-katalysierter Reaktionen
|
UA96076C2
(en)
|
2007-10-16 |
2011-09-26 |
Репрос Терапьютикс Инк. |
Use of trans-clomiphene
|
US7985325B2
(en)
*
|
2007-10-30 |
2011-07-26 |
Novellus Systems, Inc. |
Closed contact electroplating cup assembly
|
US20090162517A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Chron-Si Lai |
Chilled Nutritional Emulsions
|
US20090162494A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Chron-Si Lai |
Method of Making Chilled Nutritional Emulsions
|
US20090162522A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Chron-Si Lai |
Induced Viscosity Nutritional Emulsions Comprising A Carbohydrate-Surfactant Complex
|
US8658163B2
(en)
|
2008-03-13 |
2014-02-25 |
Curemark Llc |
Compositions and use thereof for treating symptoms of preeclampsia
|
US8084025B2
(en)
|
2008-04-18 |
2011-12-27 |
Curemark Llc |
Method for the treatment of the symptoms of drug and alcohol addiction
|
US20090324730A1
(en)
*
|
2008-06-26 |
2009-12-31 |
Fallon Joan M |
Methods and compositions for the treatment of symptoms of complex regional pain syndrome
|
US9320780B2
(en)
|
2008-06-26 |
2016-04-26 |
Curemark Llc |
Methods and compositions for the treatment of symptoms of Williams Syndrome
|
US11016104B2
(en)
|
2008-07-01 |
2021-05-25 |
Curemark, Llc |
Methods and compositions for the treatment of symptoms of neurological and mental health disorders
|
US10776453B2
(en)
*
|
2008-08-04 |
2020-09-15 |
Galenagen, Llc |
Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
|
CA2963659C
(en)
|
2008-09-17 |
2020-06-23 |
Chiasma Inc. |
Use of oral octreotride compositions
|
US20100092447A1
(en)
|
2008-10-03 |
2010-04-15 |
Fallon Joan M |
Methods and compositions for the treatment of symptoms of prion diseases
|
PL2351566T3
(pl)
*
|
2008-10-22 |
2015-06-30 |
Santen Pharmaceutical Co Ltd |
Kompozycja farmaceutyczna o ulepszonym wchłanianiu przez układ pokarmowy
|
FR2937537A1
(fr)
|
2008-10-29 |
2010-04-30 |
Centre Nat Rech Scient |
Nanoparticules de statine
|
CA2747703C
(en)
|
2009-01-06 |
2021-06-15 |
Curemark Llc |
Compositions and methods for the treatment or the prevention of infections by e. coli
|
AU2010203709B2
(en)
|
2009-01-06 |
2014-05-22 |
Galenagen, Llc |
Compositions and methods for the treatment or prevention of Staphylococcus Aureus infections and for the Eradication or reduction of Staphylococcus Aureus on surfaces
|
US11304960B2
(en)
*
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
JP6176894B2
(ja)
|
2009-03-09 |
2017-08-09 |
プロノヴァ・バイオファーマ・ノルゲ・アーエス |
脂肪酸油混合物及び界面活性剤を含む組成物、並びにその方法及び使用
|
WO2010117873A2
(en)
*
|
2009-04-06 |
2010-10-14 |
Banner Pharmacaps, Inc. |
Progesterone solutions for increased bioavailability
|
US9056050B2
(en)
|
2009-04-13 |
2015-06-16 |
Curemark Llc |
Enzyme delivery systems and methods of preparation and use
|
US8362013B2
(en)
*
|
2009-04-30 |
2013-01-29 |
Abbvie Inc. |
Salt of ABT-263 and solid-state forms thereof
|
US8728516B2
(en)
*
|
2009-04-30 |
2014-05-20 |
Abbvie Inc. |
Stabilized lipid formulation of apoptosis promoter
|
US20100297194A1
(en)
*
|
2009-04-30 |
2010-11-25 |
Nathaniel Catron |
Formulation for oral administration of apoptosis promoter
|
US20100280031A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Paul David |
Lipid formulation of apoptosis promoter
|
US20100278921A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Fischer Cristina M |
Solid oral formulation of abt-263
|
US9278070B2
(en)
|
2009-05-18 |
2016-03-08 |
Sigmoid Pharma Limited |
Composition comprising oil drops
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
TWI532484B
(zh)
*
|
2009-06-08 |
2016-05-11 |
艾伯維有限公司 |
包含凋亡促進劑之固態分散劑
|
TWI471321B
(zh)
*
|
2009-06-08 |
2015-02-01 |
Abbott Gmbh & Co Kg |
Bcl-2族群抑制劑之口服醫藥劑型
|
AU2010260208B2
(en)
|
2009-06-16 |
2014-11-13 |
Bristol-Myers Squibb Holdings Ireland Unlimited Company |
Dosage forms of apixaban
|
GB2485327A
(en)
|
2009-08-12 |
2012-05-09 |
Sigmoid Pharma Ltd |
Immunomodulatory compositions comprising a polymer matrix and an oil phase
|
US9511125B2
(en)
|
2009-10-21 |
2016-12-06 |
Curemark Llc |
Methods and compositions for the treatment of influenza
|
WO2011079127A1
(en)
*
|
2009-12-22 |
2011-06-30 |
Abbott Laboratories |
Abt-263 capsule
|
AU2010335654B2
(en)
|
2009-12-22 |
2015-04-09 |
Leo Pharma A/S |
Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants
|
CA2822435C
(en)
|
2009-12-31 |
2018-09-11 |
Differential Drug Development Associates, Llc |
Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
|
CN102753181B
(zh)
*
|
2010-01-14 |
2014-09-17 |
优麦克里尼穆德公司 |
具有改进的储存特性和溶解度特性的包含3-β-羟基-5-α-孕烷-20-酮的药物组合物
|
CA2690490C
(en)
*
|
2010-01-19 |
2012-06-26 |
Accucaps Industries Limited |
Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
|
US20110218209A1
(en)
*
|
2010-03-06 |
2011-09-08 |
Paul Daniel Yered |
Nutrient delievry drug composition
|
CN103705462B
(zh)
*
|
2010-04-12 |
2016-08-31 |
克劳拉斯医疗有限公司 |
口服睾酮酯制剂以及包含其的治疗睾酮缺乏症的方法
|
RU2012142997A
(ru)
*
|
2010-04-12 |
2014-06-20 |
Кларус Терапеутикс, Инк. |
Оральные фармацевтические композиции сложных эфиров тестостерона и способы лечения недостатка тестостерона с их использованием
|
US9375437B2
(en)
|
2010-06-18 |
2016-06-28 |
Lipocine Inc. |
Progesterone containing oral dosage forms and kits
|
MY158809A
(en)
*
|
2010-09-22 |
2016-11-15 |
Craun Res Sdn Bhd |
Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
|
US9737500B2
(en)
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US10695432B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
UA113500C2
(xx)
|
2010-10-29 |
2017-02-10 |
|
Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US9271950B2
(en)
|
2010-10-29 |
2016-03-01 |
Infirst Healthcare Limited |
Compositions for treating chronic inflammation and inflammatory diseases
|
US8895536B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating chronic inflammation and inflammatory diseases
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US9504664B2
(en)
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US10695431B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
JO3337B1
(ar)
|
2010-12-13 |
2019-03-13 |
Debiopharm Sa |
تركيبات صيدلية تشمل أليسبوريفير
|
GB2488788B
(en)
*
|
2011-03-07 |
2013-07-10 |
Natco Pharma Ltd |
Oral formulation of phenylaminopyrymidine compound with enhanced bioavailability and pharmacological response
|
WO2012123515A1
(en)
|
2011-03-14 |
2012-09-20 |
Drug Delivery Solutions Limited |
An ophthalmic composition
|
JP5976100B2
(ja)
|
2011-04-21 |
2016-08-23 |
キュアマーク リミテッド ライアビリティ カンパニー |
神経精神障害の処置のための化合物
|
US20130040923A1
(en)
|
2011-05-13 |
2013-02-14 |
Trimel Pharmaceuticals Corporation |
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
UA113291C2
(xx)
|
2011-08-04 |
2017-01-10 |
|
Метаболіти транскломіфену і їх застосування
|
US9592296B2
(en)
*
|
2011-09-08 |
2017-03-14 |
Hexal Ag |
Pharmaceutical composition for oral administration with a statin
|
KR102180667B1
(ko)
|
2011-09-29 |
2020-11-20 |
피엘엑스 옵코 인코포레이티드 |
위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법
|
HUE055562T2
(hu)
|
2011-11-23 |
2021-11-29 |
Therapeuticsmd Inc |
Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CN102525917B
(zh)
*
|
2012-01-04 |
2014-06-18 |
四川百利药业有限责任公司 |
一种尼莫地平胶束注射剂及其制备方法
|
US9452135B2
(en)
|
2012-03-20 |
2016-09-27 |
Particle Dynamics International, Llc |
Gelling agent-based dosage form
|
US10350278B2
(en)
|
2012-05-30 |
2019-07-16 |
Curemark, Llc |
Methods of treating Celiac disease
|
EP2858629A1
(de)
|
2012-06-08 |
2015-04-15 |
Leo Laboratories Limited |
Topische gelzusammensetzung mit einem ingenolderivat und einer lösungsmittelmischung
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
JP6397402B2
(ja)
*
|
2012-06-18 |
2018-09-26 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
膣内挿入用可溶性エストラジオールカプセル
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
DE102012105512A1
(de)
*
|
2012-06-25 |
2014-04-24 |
Hennig Arzneimittel Gmbh & Co. Kg |
Arzneiform zur verlängerten Freisetzung von Wirkstoffen
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
MX2015005160A
(es)
|
2012-11-02 |
2015-07-17 |
Repros Therapeutics Inc |
Trans-clomifeno para uso en terapia de cancer.
|
WO2014096139A1
(en)
|
2012-12-20 |
2014-06-26 |
Solural Pharma ApS |
Solid oral dosage form of testosterone derivative
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
WO2014128564A2
(en)
|
2013-02-21 |
2014-08-28 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical compositions of cetp inhibitors
|
GB201304662D0
(en)
|
2013-03-14 |
2013-05-01 |
Sigmoid Pharma Ltd |
Compositions
|
ES2907284T3
(es)
|
2013-03-15 |
2022-04-22 |
Marius Pharmaceuticals Llc |
Formulaciones de emulsión
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
CN103257192B
(zh)
*
|
2013-05-08 |
2014-12-24 |
北京满格医药科技有限公司 |
一种软胶囊的溶出度测定方法
|
US10201549B2
(en)
*
|
2013-06-14 |
2019-02-12 |
Professional Compounding Centers Of America (Pcca) |
Testosterone combined with anastrozole injection solutions
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
EP2878311A1
(de)
*
|
2013-11-27 |
2015-06-03 |
Freund Pharmatec Ltd. |
Verbesserung der Löslichkeit für hydrophobe Wirkstoffe
|
WO2015100406A1
(en)
|
2013-12-26 |
2015-07-02 |
Clarus Therapeutics, Inc. |
Use of oral pharmaceutical products combining testosterone esters with hypolipidemic agents
|
EP3145489A1
(de)
|
2014-05-22 |
2017-03-29 |
TherapeuticsMD, Inc. |
Natürliche kombinierte hormonersatzformulierungen und therapien
|
AU2015266850B2
(en)
|
2014-05-29 |
2019-12-05 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
KR20170020779A
(ko)
|
2014-06-17 |
2017-02-24 |
머크 샤프 앤 도메 비.브이. |
테스토스테론 운데카노에이트의 안정한 제제
|
EA036836B1
(ru)
*
|
2014-06-19 |
2020-12-25 |
Солурал Фарма Апс |
Фармацевтическая композиция для обеспечения лимфатической абсорбции липофильных соединений после еды и натощак
|
AU2015296609A1
(en)
|
2014-07-29 |
2016-12-22 |
Therapeuticsmd, Inc. |
Transdermal cream
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
KR20170102223A
(ko)
|
2014-11-07 |
2017-09-08 |
시그모이드 파마 리미티드 |
사이클로스포린을 포함하는 조성물
|
EP3253401A4
(de)
|
2015-02-03 |
2018-11-21 |
Chiasma Inc. |
Verfahren zur behandlung von krankheiten
|
EP3273796A4
(de)
*
|
2015-03-25 |
2018-11-07 |
Benemilk Oy |
Tierfutterzusammensetzungen
|
WO2016164770A1
(en)
|
2015-04-10 |
2016-10-13 |
Bioresponse, L.L.C. |
Self-emulsifying formulations of dim-related indoles
|
US20180280194A1
(en)
*
|
2015-05-20 |
2018-10-04 |
Glaukos Corporation |
Therapeutic drug compositions and implants for delivery of same
|
KR101994129B1
(ko)
|
2015-05-28 |
2019-06-28 |
닥터 레디스 레보러터리즈 리미티드 |
통증 치료를 위한 셀레콕시브 경구용 조성물
|
EP3310359A4
(de)
|
2015-06-22 |
2019-04-03 |
Lipocine Inc. |
17-hydroxyprogesteronesterhaltige orale zusammensetzungen und zugehörige verfahren
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
JP2019513151A
(ja)
|
2016-03-08 |
2019-05-23 |
ロス ガトス ファーマスーティカルズ, インク.Los Gatos Pharmaceuticals, Inc. |
カンプトテシン誘導体及びその使用
|
US10064855B2
(en)
|
2016-03-08 |
2018-09-04 |
Los Gatos Pharmaceuticals, Inc. |
Composite nanoparticles and uses thereof
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
BR112018070199A2
(pt)
|
2016-04-01 |
2019-01-29 |
Therapeuticsmd Inc |
composição farmacêutica de hormônio esteroide
|
CA3019375A1
(en)
*
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
AU2017252294B2
(en)
|
2016-04-20 |
2021-12-02 |
Dose Medical Corporation |
Bioresorbable ocular drug delivery device
|
JP2020503269A
(ja)
|
2016-11-28 |
2020-01-30 |
リポカイン インコーポレーテッド |
経口ウンデカン酸テストステロン療法
|
AU2018374029B2
(en)
|
2017-11-27 |
2024-01-11 |
Umecrine Cognition Ab |
Pharmaceutical formulation of 3a-ethynyl-3B-hydroxyandrostan-17-one oxime
|
US11607384B2
(en)
*
|
2017-12-08 |
2023-03-21 |
Western University Of Health Sciences |
Lipid emulsified drug delivery systems for chemoprevention and treatment
|
CN110013467B
(zh)
*
|
2018-01-10 |
2021-09-17 |
上海汉都医药科技有限公司 |
一种固体微粒及其制备方法和含其的药物组合物
|
EP3542788A1
(de)
|
2018-03-19 |
2019-09-25 |
MC2 Therapeutics Limited |
Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
|
US11266615B2
(en)
|
2018-06-08 |
2022-03-08 |
Harrow Ip, Llc |
Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof
|
CA3102643A1
(en)
*
|
2018-06-08 |
2019-12-12 |
Harrow Ip, Llc |
Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof
|
EP3860569A1
(de)
|
2018-10-15 |
2021-08-11 |
Cipla Limited |
Pharmazeutische formulierung
|
CN113784722A
(zh)
*
|
2019-04-11 |
2021-12-10 |
R·P·舍勒科技有限责任公司 |
用于有不良渗透性的蛋白质、肽和小分子的口服递送的制剂
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
CA3172595A1
(en)
|
2020-03-26 |
2021-09-30 |
Ronald Zimmerman |
Pharmaceutical carriers capable of ph dependent reconstitution and methods for making and using same
|
US11541009B2
(en)
|
2020-09-10 |
2023-01-03 |
Curemark, Llc |
Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
|
US11638714B2
(en)
|
2020-11-10 |
2023-05-02 |
Mountain Valley Md Inc |
Water dissolvable macrocyclic lactone cyclodextrin complexes
|
US11077134B1
(en)
|
2020-11-10 |
2021-08-03 |
Mountain Valley Md Inc |
Water dissolvable macrocyclic lactone cyclodextrin complexes
|
US11141457B1
(en)
|
2020-12-28 |
2021-10-12 |
Amryt Endo, Inc. |
Oral octreotide therapy and contraceptive methods
|
US11337987B1
(en)
|
2021-05-07 |
2022-05-24 |
Lipocine Inc. |
Compositions and methods for treating central nervous system disorders
|